Curated News
By: NewsRamp Editorial Staff
October 28, 2026
Creative Biolabs Unveils Tools for Complement & Microfluidics Research
TLDR
- Creative Biolabs offers CH50 kits and hemolysis profiling alongside droplet chips, giving complement and microfluidics researchers an edge in functional analysis.
- Creative Biolabs provides a CH50 hemolysis kit, hemolysis inhibition profiling, and a PDMS flow-focusing droplet chip for controlled functional assays.
- Creative Biolabs supports complement and microfluidics research, helping advance drug discovery and single-cell analysis for better future therapies.
- Creative Biolabs highlights CH50 functional kits and flow-focusing droplet chips, showing how specialized tools can improve experimental reproducibility and data quality.
Impact - Why it Matters
This news matters because reliable research tools are essential for advancing drug discovery and basic science. In complement therapeutics, functional assays like the CH50 kit and hemolysis inhibition profiling service enable researchers to better characterize inhibitors, potentially accelerating the development of treatments for complement-related diseases. In microfluidics, consistent droplet generation is critical for high-throughput screening and single-cell analysis, where variability can lead to wasted resources and delayed results. By offering validated solutions, Creative Biolabs helps researchers improve reproducibility and efficiency, ultimately driving progress in biotechnology and medicine.
Summary
Creative Biolabs, a provider of research tools and customized services, is highlighting a portfolio of products designed to support functional evaluation and experimental control in complement biology and droplet microfluidics. The company aims to address common challenges such as assay variability, limited functional readouts, inconsistent droplet formation, and fragmented workflows that can slow research progress. By offering specialized solutions, Creative Biolabs seeks to help researchers obtain more reliable data and streamline their experimental processes.
For complement research, Creative Biolabs offers a CH50 functional test kit, a hemolysis-based assay for measuring classical pathway activity in serum or plasma from multiple species. Additionally, the company provides a hemolysis inhibition profiling service that assesses concentration-dependent inhibition of complement-mediated lysis, aiding in inhibitor potency and mechanism-of-action studies. These functional readouts complement binding data and offer a broader view of candidate molecule effects. For microfluidics, Creative Biolabs offers a flow focusing droplet generation chip made of PDMS, designed for water-in-oil and oil-in-water droplet generation, as well as single-cell encapsulation. The chip supports controlled droplet formation for encapsulation, screening, and compartmentalized assay workflows.
By providing these tools, Creative Biolabs aims to support researchers in refining experimental workflows, broadening functional characterization, and selecting appropriate research formats. All products are for research use only. For more information, visit https://www.creative-biolabs.com/complement-therapeutics/.
Source Statement
This curated news summary relied on content distributed by 24-7 Press Release. Read the original source here, Creative Biolabs Unveils Tools for Complement & Microfluidics Research
